EAM
TLSIW icon

Exos Asset Management’s TriSalus Life Sciences Warrant TLSIW Stock Holding History

Exos Asset Management’s Portfolio TLSIW Stock Details TLSIW Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2024
Q2 		– Sell
-167,610
Closed -$168K – 156
2024
Q1 		$168K Buy
+167,610
New +$167K 0.1% 73

Other funds holding TLSIW

MF
Magnetar Financial Evanston, Illinois $9.84B AUM 190.64% 1-Year Est. Return
DM
Deerfield Management New York $8.48B AUM 99.04% 1-Year Est. Return
PAMP
Polar Asset Management Partners Toronto, Ontario, Canada $5.01B AUM 35.27% 1-Year Est. Return
VI
Vestcor Inc Fredericton, New Brunswick, Canada $3.63B AUM 21.49% 1-Year Est. Return
MP
MSD Partners New York $82.3M AUM 15.13% 1-Year Est. Return
BCM
Bluefin Capital Management New York $156M AUM 18.47% 1-Year Est. Return
BCL
Bracebridge Capital LLC Boston, Massachusetts $3.73B AUM 33.02% 1-Year Est. Return
Walleye Capital
Walleye Capital New York $24B AUM 37.67% 1-Year Est. Return
CCC
Cable Car Capital San Francisco, California $289M AUM 26.33% 1-Year Est. Return
SFA
Sequoia Financial Advisors Akron, Ohio $20.1B AUM 24.77% 1-Year Est. Return

Exos Asset Management's TLSIW Position: Q2 2024 in Review

Exos Asset Management sold out of TriSalus Life Sciences Warrant (TLSIW) in Q2 2024, closing a stake of 167,610 shares — an estimated $168K sold.

Exos Asset Management first reported a position in TLSIW in Q1 2024 and held it in 1 quarter. The position peaked at $168K in Q1 2024. 19 funds tracked by Wall St. Rank hold TLSIW as of Q2 2024.

  • Exos Asset Management reported no remaining TriSalus Life Sciences Warrant position as of Q2 2024 after selling out during the quarter.
  • Exos Asset Management sold 167,610 TriSalus Life Sciences Warrant shares in Q2 2024, an estimated $168K.
  • Exos Asset Management first reported a position in TriSalus Life Sciences Warrant in Q1 2024 and held it in 1 quarter.
  • Exos Asset Management's TriSalus Life Sciences Warrant position peaked at $168K in Q1 2024.
  • 19 funds tracked by Wall St. Rank held TriSalus Life Sciences Warrant as of Q2 2024.

Based on Exos Asset Management's 13F filing for Q2 2024, filed 14 Aug 2024.